1. Introduction
===============

The studies of epidemiology illustrated migraine, is a common disease with a 1-year prevalence of around 10% to 12% and a lifetime prevalence of between 15% and 20%.^\[[@R1]\]^ The prevalence of migraine is 14.9% in the United States, and 8.4% to 12.7% in Asia.^\[[@R2]\]^ The patients with migraine, approximately 25% to 38%, need therapy.^\[[@R3],[@R4]\]^ Although pharmacotherapies (divalproex sodium, topiramate, metoprolol, and propranolol) are advised as a means for migraines. However, many patients experience adverse effects. Data from clinical trials show that dropout rates are high, suggesting that the drugs are not accepted by patients with migraine. In recent years, emerging evidence shows the influence of behavioral interventions on patients.^\[[@R5],[@R6]\]^ But additional effective, low-risk treatments are desirable. It is a popular no pharmacological modality used for treating migraine.^\[[@R7]\]^ However, it is not simple and convenient to use requires sterile needles. Acupuncture was developed by a consensus of acupuncture experts. The patients need to remain in one position for long time during treatment.

In 2001, battlefield acupuncture was first developed by Niemtzow as an attempt to design an auricular acupuncture for reducing pain.^\[[@R9]\]^ The protocol of auricular acupuncture (cingulate gyrus, thalamus, omega-2, point zero, and Shen men) was stimulated sequentially in both ears. Auricular acupuncture is a traditional Chinese therapy according to a system of channels and meridians. It involves embedding therapy on-ear points, auricular acupoint seeds pressure, bloodletting at auricular points, auricular points on auto chemotherapy. Concerns were raised that auricular acupuncture is a simple, low-cost, and self-manageable nonpharmacological approach therapy for migraine.^\[[@R8]\]^ Previous reviews indicate that the effect of auricular acupuncture on migraine.^\[[@R9]--[@R13]\]^ Compared with acupuncture, it is a simple, safe, rapid, and effective modality in managing migraines.^\[[@R9]--[@R12]\]^ The auricular acupuncture interventions were simply developed by self after short training.^\[[@R14]\]^ However, there is a lack of evidence on the contribution of auricular acupuncture in the treatment of migraine. Therefore, this review will evaluate whether auricular acupuncture effective and safe compared with western medicine and acupuncture for the treatment of migraines. This review will be the first to evaluate the impact of auricular acupuncture.

2. Methods
==========

2.1. Eligibility criteria
-------------------------

### 2.1.1. Types of studies

We will eligible to study with randomized controlled trials (RCTs) using auricular acupuncture to treat migraines. Exclusion criteria included Quasi-RCTs.

### 2.1.2. Types of participants

We included trials in which study participants had been diagnosed with migraines, according to the definition of the Headache Classification Subcommittee of the International Headache Society, people diagnosed with migraines. The study population initially included regardless of their age, race, or sex. Patients with the following conditions were excluded: patients have had a history of subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, vascular malformation, arthritis, hypertension, arteriosclerosis, neurological diseases, immunodeficiency, and bleeding disorders or allergies.

### 2.1.3. Types of intervention

#### 2.1.3.1. Experimental interventions

Auricular acupuncture (embedding therapy on-ear point, auricular acupoint seeds pressure, bloodletting at auricular points, auricular point on autohemotherapy) will be used in the Experimental interventions group.

#### 2.1.3.2. Control interventions

The control group will consist of western medicine or body acupuncture therapy. We excluded trials comparing auricular acupuncture and western medicine with western medicine.

### 2.1.4. Types of outcome measures

#### 2.1.4.1. Primary outcome

For this study, the primary outcome is the overall effective rate.

#### 2.1.4.2. Secondary outcomes

The index of headache score and values of arteria cerebri anterior (ACA), vertebral artery (VA), middle cerebral artery (MCA) will be measured and evaluated using several instruments. Other outcomes included safety and adverse events of auricular acupuncture will be observed.

2.2. Search methods for identification of studies
-------------------------------------------------

The following databases will be searched from their inception to October 2019: Chinese National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), Wan Fang Database, the Chongqing VIP Chinese Science and Technology Periodical Database (VIP). Cochrane Library, EMBASE, EBSCO, PubMed. We will only include trials reported in English and Chinese. The search strategy for PubMed is shown in Table [1](#T1){ref-type="table"}. Other electronic databases will be used the same strategy.

###### 

Search strategy in PubMed database.

![](medi-99-e18900-g001)

2.3. Data collection and analysis
---------------------------------

### 2.3.1. Data extraction and management

The screening of studies will be conducted by 2 independent reviewers (ZF and FHJ). To assess whether the studies will be satisfied according to inclusion criteria after reading titles, abstracts, and full texts. Several studies from different opinions will be determined by the third reviewer (ZH). The study screening process is clarified for systematic reviews and meta-analyses flow chart (Fig. [1](#F1){ref-type="fig"}).

![Flow diagram of study selection process.](medi-99-e18900-g002){#F1}

### 2.3.2. Assessment of risk of bias

The assessment of risk of bias will be carried out by 2 independent reviewers (ZF and SYF), using the Cochrane Collaboration\'s "Risk of bias" tool. Study bias will be conducted as either: "unclear," "low," or "high" risk for the following criteria: random sequence generation, allocation concealment, blinding, incomplete data, selective outcome reporting, and other bias. The assessment of the bias has caused controversy, there is a need for discussion with a third reviewer (WC). The graphic representations of potential bias within and across studies using Rev Man V.5.3.5.

### 2.3.3. Measures of treatment effect

Statistical analyses will be conducted using the risk ratio with 95% confidence intervals (CIs). Odds ratio (OR) and relative risk (RR) are commonly used for dichotomous outcomes data. For continuous outcomes, the weighted mean difference (WMD) or the standard mean difference (SMD) will be analyzed.

### 2.3.4. Unit of analysis issues

The unit of analysis will be the individual participant.

### 2.3.5. Dealing with missing data

Among the results of several studies with insufficient data or missing data, the corresponding author will be contacted to complement the contents. If the corresponding author cannot be contacted, the data alone will be conducted.

### 2.3.6. Assessment of heterogeneity

The assessment of heterogeneity will be conducted by Review Manager (V.5.3.5). Chi-squared test and *I*^2^ value of the forest, plot will be calculated to assess heterogeneity, according to the Cochrane Handbook. The *I*^2^ value is classified into 4 levels: little or no heterogeneity (0%--40%), moderate heterogeneity (30%--60%), substantial heterogeneity (50%--90%), and considerable heterogeneity (75%--100%).

### 2.3.7. Assessment of reporting biases

If the numbers of available studies are sufficient, funnel plots will be assessed reporting biases.

### 2.3.8. Data synthesis

Review Manager (V.5.3.5) will be used to analyze. The test indicated little or no heterogeneity; a fixed effect model will be used for data. The random effect model will be adopted when there is considerable heterogeneity (*I*^2^ ≥ 50%). If there is considerable variation in results (*I*^2^ ≥ 75%), the meta-analysis will not be performed. The narrative and qualitative summary will be available.^\[[@R14]\]^

### 2.3.9. Subgroup analysis and investigation of heterogeneity

Subgroup analysis will be conducted to assess heterogeneity. The different types of auricular acupuncture (embedding therapy on-ear point, auricular point seeds pressure, bloodletting at auricular points, auricular point on auto chemotherapy) may be affected heterogeneity.

### 2.3.10. Sensitivity analysis

Sensitivity analysis will be used to assess the robustness of the results. It is possible to determine according to methodological quality, sample size, and analysis-related issues. The studies that follow a sequence will be removed from all the inclusion reviews. The chi-squared test and *I*^2^ value will be used to quantify statistical heterogeneity.

### 2.3.11. Summary of evidence

The assessment of evidence for all outcomes will be summarized using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. The quality of evidence will be rated as high, moderate, low, and very low quality.

3. Discussion
=============

Migraine is a disabling neurologic disorder. Despite this medical treatment, they are not necessarily effective for all patients, leading to serious adverse effects. It is no pharmacologic treatment options for migraine is required.^\[[@R14]\]^ Emerging evidence shows the influence of somatic acupuncture can be helpful in migraine treatment, but substantial data on auricular acupuncture are still lacking.^\[[@R15]\]^ Auricular acupuncture can be originated from ancient China. Studies are indicating the prevalence of use of auricular acupuncture among patients seeking migraine treatment.^\[[@R12],[@R16]--[@R19]\]^ However, although several studies exist, the scientific mechanism of the effectiveness of auricular acupuncture is not completely available. Therefore, auricular acupuncture treatment in the treatment of pain needs to be further clarified.

This systematic review will evaluate published RCTs evidence for the effectiveness and safety of auricular acupuncture for acute migraine. This study has several strengths, it may assist clinicians and patient treatment for migraine with guidelines. Clinical research will be conducted based on this systematic review protocol. Acupuncture is appealing to some patients because the inconvenient is generally limited compared with auricular acupuncture. In summary, this review will be the first to evaluate the impact of auricular acupuncture for intelligence on the treatment of migraines. A better approach may be established for the treatment of migraine base on this review. It provides reliable evidence for its extensive application.

However, this systematic review also has several limitations. The treatment of auricular acupuncture includes embedding therapy on-ear point, auricular acupoint seeds pressure, bloodletting at auricular points, and auricular point on autohemotherapy. High heterogeneity may also arise from the various evolution standards from diffident ear acupuncture therapies. The studies published in English and Chinese will be searched. Other language studies were not available.
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